The distress of psoriasis doesn't necessarily imply good treatment adherence: A lesson from the treatment of sexually transmitted disease

Journal of Dermatological Treatment

Volumn 19, Issue 3, 2008, Pages 132-133

  Awadalla, Farah C ^a   Balkrishnan, Rajesh ^b   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIPSORIASIS AGENT; DOXYCYCLINE;

CHLAMYDIASIS; DIABETES MELLITUS; DRUG USE; EDITORIAL; EMOTIONAL STRESS; GONORRHEA; HEALTH BEHAVIOR; HUMAN; INFECTION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; SEXUALLY TRANSMITTED DISEASE;

ATTITUDE TO HEALTH; HUMANS; PATIENT COMPLIANCE; PSORIASIS; QUALITY OF LIFE; SEXUALLY TRANSMITTED DISEASES;

EID: 45849113296     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630801977352     Document Type: Editorial

References (13)

1. Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health. 2001;4:392-400.
2. UK Prospective Diabetes Study Group, Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care. 1999;22:1125-36.
3. Dezii CM, Kawabata H, Tran M. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J. 2002;95:68-71.
4. Chen SC, Bayoumi AM, Soon SL, Aftergut K, Cruz P, Sexton SA, et al. A catalog of dermatology utilities: A measure of the burden of skin diseases. J Investig Dermatol Symp Proc. 2004;9:160-8.
5. Bachmann LH, Stephens J, Richey CM, Hook EW 3rd. Measured versus self-reported compliance with doxycycline therapy for Chlamydia associated syndromes: High therapeutic success rates despite poor compliance. Sex Transm Dis. 1999;26:279-80.
6. Wehbeh H, Fleisher JM, Coasino M, Ayoub A, Margossian H, Zarou D. Erythromycin for chlamydiasis in pregnant women. Assessing adherence to a standard multiday, multidose course. J Reprod Med. 2000;45:465-8.
7. Katz BP, Zwickl BW, Caine VA, Jones RB. Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis. 1992;19:351-4.
8. Augenbraun M, Bachmann L, Wallace T, Dubouchet L, McCormack W, Hook EW 3rd. Compliance with doxycycline therapy in sexually transmitted diseases clinics. Sex Transm Dis. 1998;25:1-4.
9. Sawyer R, Manavi K. An audit on the management of gonorrhoea at the Whittall Street Clinic, Birmingham, UK. Int J STD AIDS. 2007;18:354-6.
10. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140:408-14.
11. Knight KM, McGowan L, Dickens C, Bundy C. A systematic review of motivational interviewing in physical health care settings. Br J Health Psychol. 2006;11:319-32.
12. Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, et al. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clin Trials. 2002;3:371-8.
13. Brookhart MA, Patrick AR, Schneeweiss S, Avorn J, Dormuth C, Shrank W, et al. Physician follow-up and provider continuity are associated with long-term medication adherence: A study of the dynamics of statin use. Arch Intern Med. 2007;167:847-52.